Skip to main content

Interleukin Genetics Licenses DNA-Based Weight Management Algorithm from GeneOb

NEW YORK, June 21 (GenomeWeb News) - Interleukin Genetics has licensed an algorithm from GeneOb to develop a genetic weight management test, Interleukin said today.


GeneOb's technology uses specific genetic markers to determine risk of individual weight gain and response to weight-loss programs.


Interleukin Genetics intends to release its genetic weight management test next year through its commercialization partner, Alticor.


Under the licensing agreement, Interleukin Genetics has the exclusive right to market the genetic test based on GeneOb's algorithm in North America through multi-level marketing channels.


The companies also agreed to negotiate a pre-determined period license for additional products, undisclosed at this time, that use GeneOb's technology and Interleukin Genetics' expertise.


Financial terms of the agreement were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.